Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples